Morse Asset Management Inc Lowers Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Morse Asset Management Inc lessened its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.6% in the 3rd quarter, according to its most recent filing with the SEC. The firm owned 16,821 shares of the medical equipment provider’s stock after selling 281 shares during the period. Intuitive Surgical comprises 1.8% of Morse Asset Management Inc’s holdings, making the stock its 14th biggest position. Morse Asset Management Inc’s holdings in Intuitive Surgical were worth $8,264,000 as of its most recent SEC filing.

Several other hedge funds have also recently modified their holdings of ISRG. Mirador Capital Partners LP lifted its position in Intuitive Surgical by 1.4% during the third quarter. Mirador Capital Partners LP now owns 3,526 shares of the medical equipment provider’s stock valued at $1,732,000 after acquiring an additional 50 shares during the last quarter. Consolidated Planning Corp lifted its position in Intuitive Surgical by 17.4% during the third quarter. Consolidated Planning Corp now owns 8,099 shares of the medical equipment provider’s stock valued at $3,979,000 after acquiring an additional 1,198 shares during the last quarter. Healthcare of Ontario Pension Plan Trust Fund lifted its position in Intuitive Surgical by 617.1% during the second quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 89,069 shares of the medical equipment provider’s stock valued at $39,622,000 after acquiring an additional 76,649 shares during the last quarter. Swiss National Bank lifted its position in Intuitive Surgical by 0.3% during the third quarter. Swiss National Bank now owns 1,052,800 shares of the medical equipment provider’s stock valued at $517,209,000 after acquiring an additional 3,400 shares during the last quarter. Finally, ABLE Financial Group LLC purchased a new stake in Intuitive Surgical during the third quarter valued at approximately $604,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, Director Amy L. Ladd sold 450 shares of the stock in a transaction that occurred on Friday, September 13th. The shares were sold at an average price of $490.28, for a total value of $220,626.00. Following the sale, the director now directly owns 821 shares of the company’s stock, valued at approximately $402,519.88. This represents a 35.41 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, insider Jamie Samath sold 22,903 shares of the stock in a transaction that occurred on Friday, November 8th. The shares were sold at an average price of $525.00, for a total transaction of $12,024,075.00. Following the completion of the sale, the insider now directly owns 8,757 shares in the company, valued at approximately $4,597,425. This represents a 72.34 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 48,640 shares of company stock worth $25,233,553 over the last three months. Insiders own 0.90% of the company’s stock.

Intuitive Surgical Price Performance

Shares of ISRG stock opened at $543.60 on Thursday. The firm’s 50-day moving average is $518.23 and its two-hundred day moving average is $476.59. Intuitive Surgical, Inc. has a 12 month low of $314.38 and a 12 month high of $556.23. The company has a market capitalization of $193.62 billion, a PE ratio of 87.40, a price-to-earnings-growth ratio of 5.41 and a beta of 1.38.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, topping analysts’ consensus estimates of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The company had revenue of $2.04 billion for the quarter, compared to the consensus estimate of $2.01 billion. Sell-side analysts forecast that Intuitive Surgical, Inc. will post 5.45 EPS for the current year.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on the stock. Leerink Partners upped their price target on shares of Intuitive Surgical from $489.00 to $502.00 in a research note on Thursday, October 17th. Mizuho upped their price target on shares of Intuitive Surgical from $440.00 to $500.00 in a research note on Thursday, October 17th. Morgan Stanley upgraded shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and upped their price target for the company from $522.00 to $650.00 in a research note on Monday, December 2nd. Truist Financial upped their price target on shares of Intuitive Surgical from $520.00 to $570.00 and gave the company a “buy” rating in a research note on Monday, October 14th. Finally, JPMorgan Chase & Co. upped their price target on shares of Intuitive Surgical from $495.00 to $575.00 and gave the company an “overweight” rating in a research note on Friday, October 11th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Intuitive Surgical presently has an average rating of “Moderate Buy” and an average price target of $550.28.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.